Back
MaxCyte, Inc. 10K Form
Sell
42
MXCT
MaxCyte, Inc.
Last Price:
$1.51
Seasonality Move:
14.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MXCT News And Ratings
See the #1 stock for the next 7 days that we like better than MXCT
MXCT Financial Statistics
Sales & Book Value
| Annual Sales: | $38.6M |
|---|---|
| Cash Flow: | $-7.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.69 |
| Price / Book: | 0.89 |
Profitability
| EPS (TTM): | -0.42980 |
|---|---|
| Net Income (TTM): | $-45.6M |
| Gross Margin: | $27.4M |
| Return on Equity: | -23.05% |
| Return on Assets: | -19.82% |
MaxCyte, Inc. Earnings Forecast
Key MaxCyte, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for MXCT is 70.89%.
-
The Selling, General & Administrative Expenses for MXCT have been equal to 145.89% of Gross Profit Margin.
-
The Research & Development expenses have been 57.54% of Revenue.
-
The Net Earning history of MXCT is -106.29% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 4 years.
MaxCyte, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | MXCT |
| Website: | maxcyte.com |
Debt
| Debt-to-Equity Ratio: | 0.1 |
|---|---|
| Current Ratio: | 7.74 |
| Quick Ratio: | 7.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MXCT Technical Analysis vs Fundamental Analysis
Sell
42
MaxCyte, Inc. (MXCT)
is a Sell
Is MaxCyte, Inc. a Buy or a Sell?
-
MaxCyte, Inc. stock is rated a SellThe current MaxCyte, Inc. [MXCT] share price is $1.50. The Score for MXCT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.